ClinicalTrials.gg
Not yet recruitingNCT07396415TELE-BFUpdated Feb 9, 2026

Telehealth-Supported Breastfeeding Counseling in Primiparous Mothers

An interventional study of Telehealth-Supported Breastfeeding Counseling and Routine Postpartum Care in Breastfeeding, Postpartum Depression (PPD) and Breastfeeding Self-Efficacy, sponsored by Marmara University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-02-09.

Sponsored by Marmara University · Not applicable, Interventional, and Prevention

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 274 studies in Breast Feeding with a site in Turkey — 68 open to participants now, 77 under way, none of them phase 3. Breast Feeding · Turkey.

Planned enrollment
67th of 252
100 · median 80
Started
2026
with 32 others
No phase
251 of 274
65 open now
Primary completion
2027-01
later than 62 of 76 live
Registered
220th of 274
by date

Among the 274 studies in Breast Feeding with a site in Turkey, this one is the 67th largest by planned enrollment of the 252 interventional ones that give a count, is one of 33 that started in 2026, is one of 251 with no phase, reaches primary completion later than 62 of the 76 other live ones, and was the 220th registered.

Breast Feeding

1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.

Browse Breast Feeding studies →

Open to participants now

68 of the 274 studies in Breast Feeding with a site in Turkey are open now. Recruiting first, the newest first:

63 more — sign in →

All 68 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.

This study: 18 Years to 45 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 274 studies in Breast Feeding with a site in Turkey, or all of them as a file.
02

Study summary

Breastfeeding is critical for infant and maternal health; however, many first-time mothers experience difficulties that may lead to early discontinuation of breastfeeding. Telehealth-supported breastfeeding counseling has the potential to provide timely, accessible, and continuous support to mothers during the postpartum period.

This randomized controlled trial aims to evaluate the effect of telehealth-supported breastfeeding counseling on breastfeeding duration, breastfeeding self-efficacy, and postpartum depressive symptoms in primiparous mothers. Participants will be randomly assigned to either a telehealth-supported breastfeeding counseling group or a routine postpartum care group.

The intervention group will receive structured breastfeeding counseling sessions delivered via telecommunication tools in addition to standard care, while the control group will receive routine postpartum care only. Outcomes will be assessed using validated questionnaires and follow-up evaluations during the postpartum period. The findings of this study may contribute to improving breastfeeding support strategies and maternal mental health outcomes.

Read the detailed description

This study is a single-center, parallel-group, randomized controlled trial designed to investigate the effectiveness of telehealth-supported breastfeeding counseling in primiparous mothers.

Eligible participants will be primiparous women who have delivered a healthy, term, singleton infant and meet the inclusion criteria. After providing informed consent, participants will be randomly assigned in a 1:1 ratio to either the intervention group or the control group.

The intervention group will receive structured breastfeeding counseling delivered through telehealth methods, including scheduled video or telephone-based counseling sessions conducted by trained healthcare professionals, in addition to routine postpartum care. The control group will receive routine postpartum care alone.

Primary outcomes include breastfeeding self-efficacy and postpartum depressive symptoms, assessed using validated measurement tools. Secondary outcomes include breastfeeding duration and exclusive breastfeeding status during follow-up. Data will be collected at predefined time points during the postpartum period.

The study will be conducted in accordance with ethical principles and has received approval from the Marmara University Faculty of Health Sciences Non-Interventional Clinical Research Ethics Committee. The results of this study are expected to provide evidence regarding the role of telehealth-based breastfeeding support in improving maternal and infant health outcomes.

03

Conditions studied

  • Breastfeeding
  • Postpartum Depression (PPD)
  • Breastfeeding Self-Efficacy

Keywords

  • Breastfeeding Counseling
  • Telehealth
  • Primiparous Mothers
  • Postpartum Period
  • Randomized Controlled Trial
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Primiparous women aged 18-45 years.
  • Mothers who have delivered a healthy, term (≥37 weeks), singleton infant.
  • Ability to communicate in Turkish.
  • Willingness to participate in the study and provide .
  • Access to a telephone or internet-enabled device for telehealth communication.

Exclusion criteria

Exclusion Criteria:

  • Mothers with severe maternal medical or psychiatric conditions that may interfere with breastfeeding.
  • Infants with congenital anomalies or conditions affecting feeding.
  • Mothers who require neonatal intensive care admission for their infants.
  • Mothers who are unable to participate in telehealth follow-up.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Telehealth-Supported Breastfeeding Counseling

    Participants assigned to this arm will receive structured breastfeeding counseling delivered via telehealth methods, including scheduled video or telephone-based counseling sessions provided by trained healthcare professionals, in addition to routine postpartum care.

    Behavioral: Telehealth-Supported Breastfeeding Counseling

  • Active comparator
    Routine Postpartum Care

    Participants assigned to this arm will receive routine postpartum care according to standard clinical practice, without additional telehealth-supported breastfeeding counseling.

    Other: Routine Postpartum Care

Interventions

  • BehavioralTelehealth-Supported Breastfeeding Counseling

    Structured breastfeeding counseling delivered via telehealth methods, including scheduled video or telephone-based sessions conducted by trained healthcare professionals. The intervention is provided in addition to routine postpartum care and focuses on breastfeeding techniques, problem-solving, maternal support, and breastfeeding self-efficacy during the postpartum period.

  • OtherRoutine Postpartum Care

    Participants receive routine postpartum care according to standard clinical practice, without additional telehealth-supported breastfeeding counseling.

06

What researchers measure

Primary outcomes

  1. Breastfeeding Self-Efficacy

    Change in breastfeeding self-efficacy measured using a validated breastfeeding self-efficacy scale.

    Time frame: From baseline (early postpartum period) to 1 month postpartum

  2. Postpartum Depressive Symptoms

    Change in postpartum depressive symptoms assessed using the Edinburgh Postnatal Depression Scale (EPDS).

    Time frame: From baseline (early postpartum period) to 1 month postpartum

Secondary outcomes

  1. Exclusive Breastfeeding Status

    Proportion of mothers exclusively breastfeeding their infants during the follow-up period.

    Time frame: Up to 6 months postpartum

  2. Breastfeeding Duration

    Duration of breastfeeding measured as the length of time mothers continue any breastfeeding during the postpartum follow-up period.

    Time frame: Up to 6 months postpartum

07

Study locations

1 site
08

References and documents

Publications

  • Fetzer JC. How a graduate school education can meet the needs of industrial employment. Anal Bioanal Chem. 2002 Jul;373(4-5):209-10. doi: 10.1007/s00216-002-1334-7. No abstract available. PubMed 12171026 ↗
  • White RA, Thames HD Jr. State vector models of the cell cycle II: The first three moments of the transit time distribution. J Theor Biol. 1979 Mar 7;77(1):141-60. doi: 10.1016/0022-5193(79)90144-9. No abstract available. PubMed 449366 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2026; primary completion for Jan 2027, 11 months later.

Of 505 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 11 months is close to that.

Counting every sponsor, half of 513 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 2, 2026
First posted
Feb 9, 2026
StartEst.
Feb 25, 2026
Primary completionEst.
Jan 25, 2027
CompletionEst.
Feb 25, 2027
Last update
Feb 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07396415
Lead sponsor
Marmara University
Responsible party
Sponsor
First posted
Feb 9, 2026
Start date
Feb 25, 2026 (estimated)
Primary completion
Jan 25, 2027 (estimated)
Completion
Feb 25, 2027 (estimated)
Last update
Feb 9, 2026

Study contacts

Tugba Atmaca Study Contact
Contact
tugbaatmaca20@gmail.com
+905364416636

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion